Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE) - Wikidata - wikimedia - TriplyDB

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

http://www.wikidata.org/entity/Q28476101

about

T cell responses to human platelet antigen-1a involve a unique form of indirect allorecognition.Enhancing tumor vaccines: catalyzing MHC class II peptide exchange.Mechanistic understanding and significance of small peptides interaction with MHC class II molecules for therapeutic applications.

P2860

Q33435753-9DA40CD3-02E7-4A55-8EA8-43F976B84BED Q37682892-E86B6729-4119-4DA0-8D98-32F514C18B52 Q38869738-FD8647BC-14CC-4505-ABC8-71E9F10F61E0

P2860

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

http://www.wikidata.org/entity/Q28476101

description

2009 nî lūn-bûn

@nan

2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@ast

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@en

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@nl

type

label

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@ast

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@en

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@nl

prefLabel

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@ast

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@en

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@nl

P1433

Q28476101-C9A2C45E-4F9E-4E30-B2EB-3B7AFA187C46

P1476

Q28476101-E9AE4C8D-B568-4965-AF91-7A9358989F97

P2093

Q28476101-1E22724D-11D3-41F7-B2C8-2EC0772633F1

Q28476101-4C8CBAC8-5156-43FF-BD2D-B427671FC854

Q28476101-52EED4E0-EAB9-4BC5-9C7A-9D64B1336475

Q28476101-AC2F0927-338C-4900-B483-FB59BE4961B7

Q28476101-B87255F4-3B28-4839-913B-5D09A4A412F3

Q28476101-C3047EF2-6D0E-46F5-9F20-CBEDC16BC364

Q28476101-DD39CD29-6099-4B3E-A615-6E5D859257C8

Q28476101-E7114C4E-C159-4F9C-968E-15406B78EF8E

P2860

Q28476101-075CD912-9DD5-4285-A0C4-0E128E9F6E56

Q28476101-0ABA9120-C24E-45D4-ADD5-7FAD5C03D6F7

Q28476101-193665D6-C4B5-4A2D-9EC1-B4089635A639

Q28476101-1F0812C0-FC36-4AD8-B2E8-D40DF2751D2D

Q28476101-2720DD15-FA11-40EE-A90E-529943DBE269

Q28476101-31711090-5408-4735-A637-6E572D84AF81

Q28476101-3240421D-9780-4488-8BBD-F354584EDF4D

Q28476101-32C4E0FE-DE07-4D46-BF8E-894DE7FEF3C2

Q28476101-36FAE740-E73B-41F7-AC93-83178C384011

Q28476101-3C080791-F5DD-429B-9A80-E7BDF3F023E7

P304

Q28476101-55C7E354-8671-481B-813A-9E59B9F59E60

P31

Q28476101-81F9CA43-81B8-41C5-A9C3-511B63269DC1

P356

Q28476101-9F4BCBDF-A21F-42C2-8866-E3C388E04557

P407

Q28476101-8DFC0015-A358-4470-9F93-A4E0C8C5AFF3

P433

Q28476101-487B8E84-4EA1-4523-9AAD-FC06274E0105

P478

Q28476101-06D99F44-D4D9-4BC4-9BC4-41971342B1B8

P577

Q28476101-D0A27F48-89D4-4AA4-BD35-3996429603D1

P5875

Q28476101-AEB3A504-30CE-48BA-A235-004FFD5E8D72

P698

Q28476101-F6FC8789-2BF9-4496-B75C-819E1490A427

P932

Q28476101-4425BB13-D992-4408-AA4A-78CB86D16C15

P356

JOURNAL.PONE.0006811

P1433

P1476

Enhancement of tumour-specific immune responses in vivo by 'MHC loading-enhancer' (MLE)

@en

P2093

Guenther Jung

http://www.w3.org/2001/XMLSchema#string

Jamina Eckhard

http://www.w3.org/2001/XMLSchema#string

Karl-Heinz Wiesmueller

http://www.w3.org/2001/XMLSchema#string

Katharina Dickhaut

http://www.w3.org/2001/XMLSchema#string

Kirsten Falk

http://www.w3.org/2001/XMLSchema#string

Luise Schindler

http://www.w3.org/2001/XMLSchema#string

Olaf Roetzschke

http://www.w3.org/2001/XMLSchema#string

Sabine Hoepner

http://www.w3.org/2001/XMLSchema#string

P2860

A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening

Small molecules that enhance the catalytic efficiency of HLA-DM

NY-ESO-1 119-143 is a promiscuous major histocompatibility complex class II T-helper epitope recognized by Th1- and Th2-type tumor-reactive CD4+ T cells

Cancer/testis antigens: an expanding family of targets for cancer immunotherapy

Tolerance, danger, and the extended family

How dying cells alert the immune system to danger

Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor

Molecular identification of a danger signal that alerts the immune system to dying cells

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

Small organic compounds enhance antigen loading of class II major histocompatibility complex proteins by targeting the polymorphic P1 pocket.

P304

e6811

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0006811

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2009-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26797731

http://www.w3.org/2001/XMLSchema#string

P698

19738910

http://www.w3.org/2001/XMLSchema#string

P932

2735034

http://www.w3.org/2001/XMLSchema#string